These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2028183)

  • 1. Prostaglandin E2 from macrophages of murine splenocyte cultures inhibits the generation of lymphokine-activated killer cell activity.
    Ohnishi H; Lin TH; Nakajima I; Chu TM
    Tumour Biol; 1991; 12(2):99-110. PubMed ID: 2028183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2-mediated suppression of murine lymphokine-activated killer cell activity generated from tumor-bearing hosts by interferon-gamma.
    Nakajima I; Chu TM
    Mol Biother; 1990 Dec; 2(4):228-32. PubMed ID: 2126942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of murine lymphokine (rIL-2)-activated killer cell activity by indomethacin.
    Chao TY; Ohnishi H; Chu TM
    Mol Biother; 1989; 1(6):318-22. PubMed ID: 2610950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of murine lymphokine-activated killer (LAK) cell activity by adherent cells.
    Longley RE; Stewart D; Roe KG; Good RA
    Cell Immunol; 1989 Jul; 121(2):225-36. PubMed ID: 2786756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
    Saarloos MN; Khoo NK; Lala PK
    Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of hepatic lymphokine-activated killer cell induction by murine Kupffer cells and hepatocytes.
    Tzung SP; Gaines KC; Lance P; Ehrke MJ; Cohen SA
    Hepatology; 1990 Oct; 12(4 Pt 1):644-52. PubMed ID: 2210667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma.
    Chao TY; Ohnishi H; Chu TM
    Immunology; 1990 May; 70(1):116-20. PubMed ID: 2113034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of indomethacin on lymphokine-activated killer cell activities in cancer patients.
    Chao TY; Ting CS; Yeh MY; Chang JY; Wang CC; Chu TM
    Tumour Biol; 1995; 16(4):230-42. PubMed ID: 7604204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The augmentation of lymphokine-activated killer cell activity by indomethacin in vitro is not mediated by prostaglandin E2 suppression.
    Chao TY; Ting CS; Chu TM; Yeh MY
    Proc Natl Sci Counc Repub China B; 1993 Oct; 17(4):138-42. PubMed ID: 8171164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble factors produced by macrophages/monocytes inhibit lymphokine-activated killer activity in rat splenocyte cultures.
    Kuppen PJ; Eggermont AM; Quak RB; Marinelli A; van de Velde CJ; Fleuren GJ
    Cancer Immunol Immunother; 1994 Jan; 38(1):61-7. PubMed ID: 8299120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of serum half-life of interleukin 2 and augmentation of lymphokine-activated killer cell activity by pepstatin in mice.
    Ohnishi H; Lin KM; Chu TM
    Cancer Res; 1990 Feb; 50(4):1107-12. PubMed ID: 2297759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lymphokine-activated killer activity in rat splenocyte cultures: the importance of 2-mercaptoethanol and indomethacin.
    Kuppen PJ; Eggermont AM; Marinelli A; de Heer E; van de Velde CJ; Fleuren GJ
    Cancer Immunol Immunother; 1991; 33(1):28-32. PubMed ID: 2021956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of prostaglandin E2 or indomethacin on the proliferation of lymphokine-activated killer cells and their cytotoxicity against bladder tumor cells in patients with bladder cancer.
    Wang Z; Chen Y; Zheng R; Qin D; Chen X; Wang Y; Liu G
    Prostaglandins; 1997 Nov; 54(5):769-79. PubMed ID: 9491207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulatory effect of adherent cells on lymphokine activated killer cells.
    Ibayashi Y; Hoon DS; Golub SH
    Cell Immunol; 1987 Dec; 110(2):365-78. PubMed ID: 2446780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of protein kinase C in murine lymphokine-activated killer cells by retinoic acid.
    Lin TH; Chu TM
    J Biol Chem; 1992 Jan; 267(2):1335-9. PubMed ID: 1730652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity.
    Parhar RS; Yagel S; Lala PK
    Cell Immunol; 1989 Apr; 120(1):61-74. PubMed ID: 2784722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin up-regulates the generation of lymphokine-activated killer-cell activity and antibody-dependent cellular cytotoxicity mediated by interleukin-2.
    Eisenthal A
    Cancer Immunol Immunother; 1990; 31(6):342-8. PubMed ID: 2386979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of monocytes on "lymphokine activated killer" (LAK) cell activity.
    Weng XC; Mathiot C; Michon J; Andreu G; Lando D; Fridman WH
    Cancer Detect Prev; 1991; 15(3):211-5. PubMed ID: 1905581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.